LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/DJO Global Launches Vitamin E Poly, Others
Large Joints and Extremities

DJO Global Launches Vitamin E Poly, Others

March 22, 2013 2 min read Premium comments

Advertisement

DJO Global Launches Vitamin E Poly, Others
Motivation Total Knee System / Courtesy: DJO Global
Secondary

DJO Global, Inc. is putting a series of new DJO Surgical products on the red carpet at this year’s American Academy of Orthopaedic Surgeons (AAOS) meeting in Chicago on March 20-22.

e+ Technology

DJO is expanding its e+ technology—a blended vitamin e polyethylene. The latest addition includes the first ever blended vitamin e glenoid component for total shoulder arthroplasty.

Optimized Direct Anterior Approach Solutions

These solutions include the Linear dual-tapered hip stem and the Revelation microMAX anatomic hip stem with lateral flare technology.

Movation Total Knee System With e+ Technology

The Movation total knee is the next phase in the evolution of congruent PS Knee designs. Movation is a decades-long clinically successful Hospital for Special Surgery design, redefined with modern features. It is complemented by the S.U.R.E. Instrumentation System.

Trabecular Titanium Acetabular System

Advertisement

The new Trabecular Titanium Acetabular System will provide an aggressive fixation cup solution for tough primary or revision scenarios. Trabecular Titanium cups are manufactured using an electron beam melting technology, which allows the porosity to be controlled and integral to the cup (not a coating).

Bryan Monroe, senior vice president and general manager of DJO Surgical told OTW, “A lot of hard work went into launching this many products at this year’s AAOS. As with all projects, there were hurdles in the development process, but we are thrilled with the final outcome of each of the new products. We are excited to expand our e+ blended vitamin E polyethylene into our shoulder line. e+ has been a part of our knee line for over a year, and the initial results have been fantastic. We are confident that e+ will benefit patients that receive the device. e+ differs from other vitamin E polyethylene products in the way that the vitamin E is introduced into the polyethylene material. While a number of products on the market are ‘infused’ with vitamin E, meaning the vitamin E is added to the part after it is manufactured, e+ is blended directly into the resin for a more uniform distribution of the vitamin E within the polyethylene. This should help the material retain improved mechanical and wear properties throughout the part.”

He added, “The Movation Total Knee System is our latest knee system based on patented technology from the Hospital for Special Surgery (HSS). The so called ‘913’ patent has become known as the gold standard for PCL substituting knee designs, and we have been able to license and leverage the critical aspects of the patent. In addition, we have added several contemporary features to improve on an already well proven design. The Movation knee, as with any knee system, was a huge undertaking due to the number of size options in the system. We are pleased that we are able to launch the full product, complete with e+ technology at this year’s AAOS.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy